These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 31626823)

  • 1. Tuberculosis control in crisis-causes and solutions.
    Kaplan G
    Prog Biophys Mol Biol; 2020 May; 152():6-9. PubMed ID: 31626823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improving diagnosis and case management of patients with tuberculosis: A review of gaps, needs and potential solutions in accessing laboratory diagnostics.
    Andama A; Somoskovi A; Mandel B; Bell D; Gutierrez C
    Infect Genet Evol; 2019 Aug; 72():131-140. PubMed ID: 30326281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plan to combat extensively drug-resistant tuberculosis: recommendations of the Federal Tuberculosis Task Force.
    Centers for Disease Control and Prevention (CDC)
    MMWR Recomm Rep; 2009 Feb; 58(RR-3):1-43. PubMed ID: 19214162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tuberculosis: a new vision for the 21st century.
    Small PM
    Kekkaku; 2009 Nov; 84(11):721-6. PubMed ID: 19999594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How research can help control tuberculosis.
    Chaisson RE; Harrington M
    Int J Tuberc Lung Dis; 2009 May; 13(5):558-68. PubMed ID: 19383187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M; Shirakawa T
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Reform of Japan's NTP and its technical perspectives].
    Mori T
    Kekkaku; 2004 Oct; 79(10):587-604. PubMed ID: 15631111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Achieving STOP TB Partnership goals: perspectives on development of new diagnostics, drugs and vaccines for tuberculosis.
    Mwaba P; McNerney R; Grobusch MP; O'Grady J; Bates M; Kapata N; Maeurer M; Zumla A
    Trop Med Int Health; 2011 Jul; 16(7):819-27. PubMed ID: 21489070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiological benefits of more-effective tuberculosis vaccines, drugs, and diagnostics.
    Abu-Raddad LJ; Sabatelli L; Achterberg JT; Sugimoto JD; Longini IM; Dye C; Halloran ME
    Proc Natl Acad Sci U S A; 2009 Aug; 106(33):13980-5. PubMed ID: 19666590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What is operational research and how can national tuberculosis programmes in low- and middle-income countries use it to end TB?
    Kumar AM; Harries AD; Satyanarayana S; Thekkur P; Shewade HD; Zachariah R
    Indian J Tuberc; 2020 Dec; 67(4S):S23-S32. PubMed ID: 33308668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Global Burden of Latent Tuberculosis Infection: A Re-estimation Using Mathematical Modelling.
    Houben RM; Dodd PJ
    PLoS Med; 2016 Oct; 13(10):e1002152. PubMed ID: 27780211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. National action plan to combat multidrug-resistant tuberculosis.
    MMWR Recomm Rep; 1992 Jun; 41(RR-11):5-48. PubMed ID: 1640920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fighting the tuberculosis epidemic in the Western Pacific region: current situation and challenges ahead.
    van Maaren PJ
    Kekkaku; 2010 Jan; 85(1):9-16. PubMed ID: 20143671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Controlling tuberculosis in the United States. Recommendations from the American Thoracic Society, CDC, and the Infectious Diseases Society of America.
    Taylor Z; Nolan CM; Blumberg HM; ; ;
    MMWR Recomm Rep; 2005 Nov; 54(RR-12):1-81. PubMed ID: 16267499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TB Anywhere is TB Everywhere.
    Wortham JM
    Isr J Health Policy Res; 2018 Jul; 7(1):40. PubMed ID: 30029612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Importance of differential identification of Mycobacterium tuberculosis strains for understanding differences in their prevalence, treatment efficacy, and vaccine development.
    Chae H; Shin SJ
    J Microbiol; 2018 May; 56(5):300-311. PubMed ID: 29721826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV infection and multidrug-resistant tuberculosis: the perfect storm.
    Wells CD; Cegielski JP; Nelson LJ; Laserson KF; Holtz TH; Finlay A; Castro KG; Weyer K
    J Infect Dis; 2007 Aug; 196 Suppl 1():S86-107. PubMed ID: 17624830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Global Epidemiology of Tuberculosis and Progress Toward Meeting Global Targets - Worldwide, 2018.
    MacNeil A; Glaziou P; Sismanidis C; Date A; Maloney S; Floyd K
    MMWR Morb Mortal Wkly Rep; 2020 Mar; 69(11):281-285. PubMed ID: 32191687
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.